Glaxo wins US FDA approval for wider Advair use - Reuters
Glaxo wins US FDA approval for wider Advair use Reuters - 39 minutes ago N: Quote, Profile, Research) Advair is safe and effective to more widely treat patients with chronic obstructive pulmonary disease (COPD), the drugmaker ... |